Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00770263
Title Erlotinib and Temsirolimus for Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

Advanced Solid Tumor

adenoid cystic carcinoma

thyroid gland papillary carcinoma

squamous cell carcinoma

Therapies

Erlotinib + Temsirolimus

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST